<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35942159</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2768-0622</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Clinical and translational discovery</Title><ISOAbbreviation>Clin Transl Discov</ISOAbbreviation></Journal><ArticleTitle>The current status of gene expression profilings in COVID-19 patients.</ArticleTitle><Pagination><StartPage>e104</StartPage><MedlinePgn>e104</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e104</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/ctd2.104</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The global pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has swept through every part of the world. Because of its impact, international efforts have been underway to identify the variants of SARS-CoV-2 by genome sequencing and to understand the gene expression changes in COVID-19 patients compared to healthy donors using RNA sequencing (RNA-seq) assay. Within the last two and half years since the emergence of SARS-CoV-2, a large number of OMICS data of COVID-19 patients have accumulated. Yet, we are still far from understanding the disease mechanism. Further, many people suffer from long-term effects of COVID-19; calling for a more systematic way to data mine the generated OMICS data, especially RNA-seq data.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">By searching gene expression omnibus (GEO) using the key terms, COVID-19 and RNA-seq, 108 GEO entries were identified. Each of these studies was manually examined to categorize the studies into bulk or single-cell RNA-seq (scRNA-seq) followed by an inspection of their original articles.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The currently available RNA-seq data were generated from various types of patients' samples, and COVID-19 related sample materials have been sequenced at the level of RNA, including whole blood, different components of blood [e.g., plasma, peripheral blood mononuclear cells (PBMCs), leukocytes, lymphocytes, monocytes, T cells], nasal swabs, and autopsy samples (e.g., lung, heart, liver, kidney). Of these, RNA-seq studies using whole blood, PBMCs, nasal swabs and autopsy/biopsy samples were reviewed to highlight the major findings from RNA-seq data analysis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Based on the bulk and scRNA-seq data analysis, severe COVID-19 patients display shifts in cell populations, especially those of leukocytes and monocytes, possibly leading to cytokine storms and immune silence. These RNA-seq data form the foundation for further gene expression analysis using samples from individuals suffering from long COVID.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Clinical and Translational Discovery published by John Wiley &amp; Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ilieva</LastName><ForeName>Mirolyuba</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7992-8885</Identifier><AffiliationInfo><Affiliation>Center for RNA Medicine, Department of Clinical Medicine Aalborg University Copenhagen Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tschaikowski</LastName><ForeName>Max</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Computer Science Aalborg University Aalborg Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vandin</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Economics and EMbeDS Sant'Anna School of Advanced Studies Pisa Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Applied Mathematics and Computer Science Technical University of Denmark Kongens Lyngby Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uchida</LastName><ForeName>Shizuka</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4787-8067</Identifier><AffiliationInfo><Affiliation>Center for RNA Medicine, Department of Clinical Medicine Aalborg University Copenhagen Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Transl Discov</MedlineTA><NlmUniqueID>9918266190206676</NlmUniqueID><ISSNLinking>2768-0622</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID&#x2010;19</Keyword><Keyword MajorTopicYN="N">RNA&#x2010;seq</Keyword><Keyword MajorTopicYN="N">biomarker</Keyword><Keyword MajorTopicYN="N">gene expression</Keyword></KeywordList><CoiStatement>The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>9</Day><Hour>2</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35942159</ArticleId><ArticleId IdType="pmc">PMC9350144</ArticleId><ArticleId IdType="doi">10.1002/ctd2.104</ArticleId><ArticleId IdType="pii">CTD2104</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Morales AC, Rice AM, Ho AT, et&#xa0;al. Causes and consequences of purifying selection on SARS&#x2010;CoV&#x2010;2. Genome Biol Evol. 2021;13(10):evab196. 10.1093/gbe/evab196</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gbe/evab196</ArticleId><ArticleId IdType="pmc">PMC8504154</ArticleId><ArticleId IdType="pubmed">34427640</ArticleId></ArticleIdList></Reference><Reference><Citation>Palaiodimos L, Kokkinidis DG, Li W, et&#xa0;al. Severe obesity, increasing age and male sex are independently associated with worse in&#x2010;hospital outcomes, and higher in&#x2010;hospital mortality, in a cohort of patients with COVID&#x2010;19 in the Bronx, New York. Metabolism. 2020;108:154262. 10.1016/j.metabol.2020.154262</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2020.154262</ArticleId><ArticleId IdType="pmc">PMC7228874</ArticleId><ArticleId IdType="pubmed">32422233</ArticleId></ArticleIdList></Reference><Reference><Citation>Goertz YMJ, Van Herck M, Delbressine JM, et&#xa0;al. Persistent symptoms 3 months after a SARS&#x2010;CoV&#x2010;2 infection: the post&#x2010;COVID&#x2010;19 syndrome? ERJ Open Res. 2020;6(4):00542&#x2010;2020. 10.1183/23120541.00542-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain U. Effect of COVID&#x2010;19 on the Organs. Cureus. 2020;12(8):e9540. 10.7759/cureus.9540</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.9540</ArticleId><ArticleId IdType="pmc">PMC7470660</ArticleId><ArticleId IdType="pubmed">32905500</ArticleId></ArticleIdList></Reference><Reference><Citation>Iadecola C, Anrather J, Kamel H. Effects of COVID&#x2010;19 on the nervous system. Cell. 2020;183(1):16&#x2010;27 e1. 10.1016/j.cell.2020.08.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.028</ArticleId><ArticleId IdType="pmc">PMC7437501</ArticleId><ArticleId IdType="pubmed">32882182</ArticleId></ArticleIdList></Reference><Reference><Citation>Vo GV, Bagyinszky E, An SSA. COVID&#x2010;19 genetic variants and their potential impact in vaccine development. Microorganisms. 2022;10(3):10030598. 10.3390/microorganisms10030598</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms10030598</ArticleId><ArticleId IdType="pmc">PMC8954257</ArticleId><ArticleId IdType="pubmed">35336173</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lancet Infectious D . Explaining the unexplained hepatitis in children. Lancet Infect Dis. 2022;22:74310.1016/S1473-3099(22)00296-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00296-1</ArticleId><ArticleId IdType="pubmed">35569492</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy Y, Wiedemann A, Hejblum BP, et&#xa0;al. CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death. iScience. 2021;24(7):102711. 10.1016/j.isci.2021.102711</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.102711</ArticleId><ArticleId IdType="pmc">PMC8189740</ArticleId><ArticleId IdType="pubmed">34127958</ArticleId></ArticleIdList></Reference><Reference><Citation>Carapito R, Li R, Helms J, et&#xa0;al. Identification of driver genes for critical forms of COVID&#x2010;19 in a deeply phenotyped young patient cohort. Sci Transl Med. 2022;14(628):eabj7521. 10.1126/scitranslmed.abj7521</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abj7521</ArticleId><ArticleId IdType="pubmed">34698500</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares&#x2010;Schanoski A, Sauerwald N, Goforth CW, et&#xa0;al. Asymptomatic SARS&#x2010;CoV&#x2010;2 infection is associated with higher levels of serum IL&#x2010;17C, matrix metalloproteinase 10 and fibroblast growth factors than mild symptomatic COVID&#x2010;19. Front Immunol. 2022;13:821730. 10.3389/fimmu.2022.821730</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.821730</ArticleId><ArticleId IdType="pmc">PMC9037090</ArticleId><ArticleId IdType="pubmed">35479098</ArticleId></ArticleIdList></Reference><Reference><Citation>He D, Yang CX, Sahin B, et&#xa0;al. Whole blood vs PBMC: compartmental differences in gene expression profiling exemplified in asthma. Allergy Asthma Clin Immunol. 2019;15:67. 10.1186/s13223-019-0382-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13223-019-0382-x</ArticleId><ArticleId IdType="pmc">PMC6873413</ArticleId><ArticleId IdType="pubmed">31832069</ArticleId></ArticleIdList></Reference><Reference><Citation>Riedhammer C, Halbritter D, Weissert R. Peripheral blood mononuclear cells: isolation, freezing, thawing, and culture. Methods Mol Biol. 2016;1304:53&#x2010;61. 10.1007/7651_2014_99</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/7651_2014_99</ArticleId><ArticleId IdType="pubmed">25092056</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Bai H, Ma J, et&#xa0;al. Identification of distinct immune cell subsets associated with asymptomatic infection, disease severity, and viral persistence in COVID&#x2010;19 patients. Front Immunol. 2022;13:812514. 10.3389/fimmu.2022.812514</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.812514</ArticleId><ArticleId IdType="pmc">PMC8905648</ArticleId><ArticleId IdType="pubmed">35281000</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen NT, Chinn J, De Ferrante M, Kirby KA, Hohmann SF, Amin A. Male gender is a predictor of higher mortality in hospitalized adults with COVID&#x2010;19. PLoS One. 2021;16(7):e0254066. 10.1371/journal.pone.0254066</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254066</ArticleId><ArticleId IdType="pmc">PMC8270145</ArticleId><ArticleId IdType="pubmed">34242273</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu C, Littleton S, Giroux NS, et&#xa0;al. Mucosal&#x2010;associated invariant T cell responses differ by sex in COVID&#x2010;19. Med (N Y). 2021;2(6):755&#x2010;772. 10.1016/j.medj.2021.04.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2021.04.008</ArticleId><ArticleId IdType="pmc">PMC8043578</ArticleId><ArticleId IdType="pubmed">33870241</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo C, Li B, Ma H, et&#xa0;al. Single&#x2010;cell analysis of two severe COVID&#x2010;19 patients reveals a monocyte&#x2010;associated and tocilizumab&#x2010;responding cytokine storm. Nat Commun. 2020;11(1):3924. 10.1038/s41467-020-17834-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17834-w</ArticleId><ArticleId IdType="pmc">PMC7413381</ArticleId><ArticleId IdType="pubmed">32764665</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh NK, Srivastava S, Zaveri L, et&#xa0;al. Host transcriptional response to SARS&#x2010;CoV&#x2010;2 infection in COVID&#x2010;19 patients. Clin Transl Med. 2021;11(9):e534. 10.1002/ctm2.534</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ctm2.534</ArticleId><ArticleId IdType="pmc">PMC8453261</ArticleId><ArticleId IdType="pubmed">34586723</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng DL, Granados AC, Santos YA, et&#xa0;al. A diagnostic host response biosignature for COVID&#x2010;19 from RNA profiling of nasal swabs and blood. Sci Adv. 2021;7(6):eabe5984. 10.1126/sciadv.abe5984</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abe5984</ArticleId><ArticleId IdType="pmc">PMC7857687</ArticleId><ArticleId IdType="pubmed">33536218</ArticleId></ArticleIdList></Reference><Reference><Citation>Caniego&#x2010;Casas T, Martinez&#x2010;Garcia L, Alonso&#x2010;Riano M, et&#xa0;al. RNA SARS&#x2010;CoV&#x2010;2 persistence in the lung of severe COVID&#x2010;19 patients: a case series of autopsies. Front Microbiol. 2022;13:824967. 10.3389/fmicb.2022.824967</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.824967</ArticleId><ArticleId IdType="pmc">PMC8841799</ArticleId><ArticleId IdType="pubmed">35173701</ArticleId></ArticleIdList></Reference><Reference><Citation>Delorey TM, Ziegler CGK, Heimberg G, et&#xa0;al. COVID&#x2010;19 tissue atlases reveal SARS&#x2010;CoV&#x2010;2 pathology and cellular targets. Nature. 2021;595(7865):107&#x2010;113. 10.1038/s41586-021-03570-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03570-8</ArticleId><ArticleId IdType="pmc">PMC8919505</ArticleId><ArticleId IdType="pubmed">33915569</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H, He P, Ren Y, et&#xa0;al. Postmortem high&#x2010;dimensional immune profiling of severe COVID&#x2010;19 patients reveals distinct patterns of immunosuppression and immunoactivation. Nat Commun. 2022;13(1):269. 10.1038/s41467-021-27723-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27723-5</ArticleId><ArticleId IdType="pmc">PMC8755743</ArticleId><ArticleId IdType="pubmed">35022412</ArticleId></ArticleIdList></Reference><Reference><Citation>Pujadas E, Beaumont M, Shah H, et&#xa0;al. Molecular profiling of coronavirus disease 2019 (COVID&#x2010;19) autopsies uncovers novel disease mechanisms. Am J Pathol. 2021;191(12):2064&#x2010;2071. 10.1016/j.ajpath.2021.08.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2021.08.009</ArticleId><ArticleId IdType="pmc">PMC8423774</ArticleId><ArticleId IdType="pubmed">34506752</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai N, Neyaz A, Szabolcs A, et&#xa0;al. Temporal and spatial heterogeneity of host response to SARS&#x2010;CoV&#x2010;2 pulmonary infection. Nat Commun. 2020;11(1):6319. 10.1038/s41467-020-20139-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20139-7</ArticleId><ArticleId IdType="pmc">PMC7725958</ArticleId><ArticleId IdType="pubmed">33298930</ArticleId></ArticleIdList></Reference><Reference><Citation>Bost P, De Sanctis F, Cane S, et&#xa0;al. Deciphering the state of immune silence in fatal COVID&#x2010;19 patients. Nat Commun. 2021;12(1):1428. 10.1038/s41467-021-21702-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21702-6</ArticleId><ArticleId IdType="pmc">PMC7935849</ArticleId><ArticleId IdType="pubmed">33674591</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Li X, Gu X, et&#xa0;al. Health outcomes in people 2 years after surviving hospitalisation with COVID&#x2010;19: a longitudinal cohort study. Lancet Respir Med. 2022;S2213&#x2010;2600(22):00126&#x2010;6. 10.1016/S2213-2600(22)00126-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00126-6</ArticleId><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghandikota S, Sharma M, Jegga AG. Computational workflow for functional characterization of COVID&#x2010;19 through secondary data analysis. STAR Protoc. 2021;2(4):100873. 10.1016/j.xpro.2021.100873</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xpro.2021.100873</ArticleId><ArticleId IdType="pmc">PMC8551262</ArticleId><ArticleId IdType="pubmed">34746856</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y, Xu X, Kitanovski S, et&#xa0;al. Comprehensive comparison of RNA&#x2010;Seq data of SARS&#x2010;CoV&#x2010;2, SARS&#x2010;CoV and MERS&#x2010;CoV infections: alternative entry routes and innate immune responses. Front Immunol. 2021;12:656433. 10.3389/fimmu.2021.656433</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.656433</ArticleId><ArticleId IdType="pmc">PMC8195239</ArticleId><ArticleId IdType="pubmed">34122413</ArticleId></ArticleIdList></Reference><Reference><Citation>Jha PK, Vijay A, Halu A, Uchida S, Aikawa M. Gene expression profiling reveals the shared and distinct transcriptional signatures in human lung epithelial cells infected with SARS&#x2010;CoV&#x2010;2, MERS&#x2010;CoV, or SARS&#x2010;CoV: potential implications in cardiovascular complications of COVID&#x2010;19. Front Cardiovasc Med. 2020;7:623012. 10.3389/fcvm.2020.623012</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2020.623012</ArticleId><ArticleId IdType="pmc">PMC7844200</ArticleId><ArticleId IdType="pubmed">33521069</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalli E, Petralia MC, Basile MS, et&#xa0;al. Transcriptomic analysis of COVID19 lungs and bronchoalveolar lavage fluid samples reveals predominant B cell activation responses to infection. Int J Mol Med. 2020;46(4):1266&#x2010;1273. 10.3892/ijmm.2020.4702</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2020.4702</ArticleId><ArticleId IdType="pmc">PMC7447313</ArticleId><ArticleId IdType="pubmed">32945352</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>